Biotelemetry, inc. (BEAT)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Sep'12Jun'12
Revenue:
Healthcare

-

-

-

-

-

-

-

-

-

-

-

-

42,511

-

40,395

42,165

41,149

39,040

35,687

36,255

34,981

35,062

34,662

34,160

29,294

26,492

24,279

24,910

24,705

23,321

24,517

Research

-

-

-

-

-

-

-

-

-

-

-

-

9,324

-

10,420

7,896

5,393

5,500

5,484

5,441

5,428

4,881

4,778

5,245

4,840

4,243

5,962

5,252

4,872

2,220

479

Other

-

-

-

-

-

-

-

-

-

-

-

-

4,046

-

2,240

2,619

2,098

2,234

2,321

3,116

3,026

3,710

3,673

3,245

3,028

2,370

1,633

1,942

2,841

1,499

2,454

Revenue

113,031

112,034

111,291

111,803

103,979

103,603

100,013

101,360

94,496

91,743

81,023

58,129

55,881

53,957

53,055

52,680

48,640

46,774

43,492

44,812

43,435

43,653

43,113

42,650

37,162

33,105

31,874

32,104

32,418

27,040

27,450

Cost of revenue:
Healthcare

-

-

-

-

-

-

-

-

-

-

-

-

14,648

-

13,030

13,470

13,162

13,394

12,314

12,808

13,177

14,221

14,753

14,842

11,126

7,854

8,734

8,827

8,764

9,098

9,313

Research

-

-

-

-

-

-

-

-

-

-

-

-

5,571

-

5,604

4,447

3,255

3,322

3,220

3,233

2,953

2,602

2,563

2,725

2,756

3,114

2,696

2,769

2,738

997

160

Other

-

-

-

-

-

-

-

-

-

-

-

-

2,753

-

1,555

1,842

1,596

1,794

1,621

2,038

2,082

2,301

2,119

1,470

1,636

1,342

1,210

1,012

1,371

547

1,251

Cost of revenue

42,523

42,117

41,952

41,563

39,201

39,657

37,276

35,605

36,448

37,318

31,954

22,162

22,972

20,921

20,189

19,759

18,013

18,510

17,155

18,079

18,212

19,124

19,435

19,037

15,518

12,310

12,640

12,608

12,873

10,642

10,724

Gross profit

70,508

69,917

69,339

70,240

64,778

63,946

62,737

65,755

58,048

54,425

49,069

35,967

32,909

33,036

32,866

32,921

30,627

28,264

26,337

26,733

25,223

24,529

23,678

23,613

21,644

20,795

19,234

19,496

19,545

16,398

16,726

Operating expenses:
General and administrative

31,881

32,248

29,651

30,587

27,607

27,951

26,325

28,741

26,719

27,380

25,320

14,366

15,917

15,300

13,853

14,388

12,336

12,782

11,497

12,206

11,397

12,233

10,987

11,139

10,772

9,005

8,959

9,077

9,528

7,969

7,635

Sales and marketing

13,446

12,857

12,572

12,795

12,440

10,314

10,120

11,075

11,340

10,271

9,719

7,631

7,701

6,949

7,018

7,124

7,545

7,195

6,632

6,926

7,183

6,894

7,299

7,172

7,440

6,538

6,708

6,267

6,762

6,476

6,027

Credit loss expense

6,020

5,415

5,858

5,379

5,148

5,289

5,157

6,875

4,879

4,325

3,768

2,416

2,791

2,134

2,495

2,664

2,638

1,278

2,245

2,175

2,349

2,375

1,868

2,745

2,359

1,926

1,427

1,967

2,467

3,195

2,959

Research and development

3,568

3,468

3,661

3,532

3,333

2,755

2,429

2,733

3,289

2,876

3,277

2,515

2,433

2,467

2,137

1,965

1,786

1,950

1,565

1,631

1,965

1,656

1,993

1,958

1,789

1,938

1,898

1,882

1,620

1,143

1,040

Other charges

2,084

7,102

2,598

2,234

3,070

3,036

1,330

5,208

5,085

16,894

8,152

4,651

1,739

2,795

2,397

1,659

1,788

1,601

1,392

1,210

1,860

2,073

1,045

1,000

2,980

1,162

3,077

2,541

1,202

741

733

Total operating expenses

56,999

61,058

54,340

54,527

51,598

49,367

45,361

54,632

51,312

61,737

50,236

31,579

30,581

29,645

27,900

27,800

26,093

24,806

23,331

24,148

24,754

25,231

23,192

24,014

25,340

20,569

22,069

21,734

21,579

19,524

18,394

Income from operations

13,509

8,859

14,999

15,713

13,180

14,579

17,376

11,123

6,736

-7,312

-1,167

4,388

2,328

3,391

4,966

5,121

4,534

3,458

3,006

2,585

469

-702

486

-401

-3,696

226

-2,835

-2,238

-2,034

-3,126

-1,668

Other expense:
Other expense:
Interest expense

2,107

2,124

2,338

2,538

2,482

2,447

2,408

2,684

1,890

2,276

1,841

392

388

-

544

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Gain (Loss) on Extinguishment of Debt

-

-

-

-

-

-

-

-

-

-

-543

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss on equity method investments

0

-1,047

-65

-154

-32

-8

-54

-45

-139

-82

-106

-101

-95

-

-69

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Other non-operating income/(expense), net

931

-430

-845

86

-1,054

822

-194

550

187

-53

658

-899

-2,515

-

-17

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Total other expense, net

-1,176

-3,601

-3,248

-2,606

-3,568

-1,633

-2,656

-2,179

-1,842

-2,411

-1,832

-1,392

-2,998

-556

-630

-633

-423

-402

-391

-439

-390

-642

-293

-3,587

-3,271

-

-

-

-

5

39

Interest and other loss, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-97

-61

-53

-

-

Income before income taxes

12,333

5,258

11,751

13,107

9,612

12,946

14,720

8,944

4,894

-9,723

-2,999

2,996

-670

2,835

4,336

4,488

4,111

3,056

2,615

2,146

79

-1,344

193

-3,988

-6,967

214

-2,932

-2,299

-2,087

-3,121

-1,629

(Provision for)/benefit from income taxes

5,200

3,684

3,500

4,800

-2,100

2,572

-1,300

-1,500

-142

6,778

-435

1,270

-866

-37,613

141

-209

14

208

137

-25

148

310

222

0

-2,845

-

24

-

-

-

-431

Net income

7,109

1,576

8,283

8,300

11,685

10,393

16,001

10,444

5,036

-16,501

-2,564

1,726

196

-

4,195

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss attributable to noncontrolling interests

-

-

0

0

-

0

0

0

-946

-908

-279

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net Income (Loss) Available to Common Stockholders, Basic

-

-

8,283

8,300

-

10,393

16,001

10,444

5,982

-15,593

-2,285

1,726

196

40,448

4,195

4,697

4,097

-

2,478

2,171

-69

-1,654

-29

-3,988

-4,122

-

-

-

-

-3,121

-1,198

Other comprehensive income/(loss):
Foreign currency translation loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

150

-150

2

-4

1

2

-11

-

-

-

-

-

-

-

-

-

-

Unrealized holding gains/(losses) arising during the period

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4

Comprehensive income/(loss) attributable to BioTelemetry, Inc.

-

-

-

-

-

-

-

-

-

-

-

-

-

-

4,345

4,547

4,099

2,844

2,479

2,173

-80

-

-29

-3,988

-

23

-2,956

-2,299

-2,087

-

-1,194

Net income per common share:
Basic (in dollars per share)

0.21

0.04

0.24

0.25

0.35

0.33

0.48

0.32

0.18

-0.53

-0.07

0.06

0.01

1.44

0.15

0.17

0.15

0.10

0.09

0.08

0.00

-

0.00

-0.15

-

-

-

-

-

-

-

Diluted (in dollars per share)

0.19

0.04

0.23

0.23

0.32

0.29

0.45

0.29

0.17

-0.52

-0.07

0.05

0.01

1.32

0.14

0.15

0.14

0.10

0.08

0.08

0.00

-

0.00

-0.15

-

-

-

-

-

-

-

Basic and diluted (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.16

-

-0.12

-0.09

-0.08

-0.12

-0.05

Weighted average number of common shares outstanding:
Basic (in shares)

34,186

34,405

33,908

33,825

33,654

32,828

33,003

32,435

32,570

32,531

31,897

28,687

28,429

28,246

28,102

27,960

27,370

27,276

27,181

27,071

26,934

-

26,521

26,434

-

-

-

-

-

-

-

Dilutive common stock equivalents (in shares)

2,403

2,363

2,360

2,493

2,752

3,573

2,915

3,143

2,665

-5,872

0

2,986

2,886

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted (in shares)

36,589

36,768

36,268

36,318

36,406

36,401

35,918

35,578

35,235

26,659

31,897

31,673

31,315

31,037

30,880

30,516

29,521

31,192

29,311

28,918

26,934

-

26,521

26,434

-

-

-

-

-

-

-

Basic and diluted (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

26,110

-

25,616

25,537

25,190

24,995

24,918

Anti-dilutive stock options and restricted stock units excluded from weighted average calculation (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

496

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-